Type I Hypersensitivity: Pathogenesis and clinical findings
Definition: Production of lgE Antibodies that bind to harmless allergens and induce mast cell degranulation, leading to an allergic reaction.
"Sensitization" to Allergen:
Initial exposure to allergen (ex. dust, pollen, foods, drugs) -> Patient's immune system mistakenly recognizes allergen as potentially harmful -> Formation of allergen-specific plasma cells that secrete lgE-antibodies -> Allergen-specific lgE Abs persist in body after clearance of allergen
Second Exposure to Allergen:
Pre-formed lgE binds allergen, creating an allergen-antibody complex ->
Allergen-antibody complexes bind to mast cells, causing them to "degranulate": release the pro-inflammatory molecules within them (i.e. histamine) into the blood
=>
• Increased Vascular permeability
• Smooth muscle contraction in airways
• Mucus secretion
• Inflammatory cells recruited
Complications:
• Acute Asthma
• Antibiotic Allergies (ex. penicillin & cephalosporin)
• Food Allergies (ex. peanuts)
• Hay fever (allergic rhinitis to airborne particles like pollen & dust)
• Urticaria (hives)
• Allergic conjunctivitis
• Anaphylaxis
#TypeI #Type1 #HypersensitivityReaction #Allergy #Immunology #pathophysiology